University of Pennsylvania — Philadelphia, Pennsylvania

Public research footprint of University of Pennsylvania, compiled from the ClinicalTrials.gov public registry.

5,038

Registered studies

1,295

Active

670

Recruiting now

2,958

Completed

664

Stopped or withdrawn

Most-studied conditions

EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified · Acute Myeloid Leukemia · Stage II Lung Cancer AJCC v8 · Von Hippel-Lindau Disease

Recently updated registry entries

NCT06952504 — A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab… (Recruiting)
NCT04924075 — Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL)… (Recruiting)
NCT06317649 — Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at University of Pennsylvania?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.